Rcombinant Cynomolgus TNFSF13B, Fc-tagged species: Cynomolgus
- Known as:
- Rcombinant Cynomolgus TNFSF13B, Fc-tagged species: Cynomolgus
- Catalog number:
- tnfsf13b-136c
- Product Quantity:
- USD
- Category:
- -
- Supplier:
- Biomart
- Gene target:
- Rcombinant Cynomolgus TNFSF13B Fc-tagged species:
Related genes to: Rcombinant Cynomolgus TNFSF13B, Fc-tagged species: Cynomolgus
- Gene:
- TNFSF13B NIH gene
- Name:
- TNF superfamily member 13b
- Previous symbol:
- TNFSF20
- Synonyms:
- BAFF, THANK, BLYS, TALL-1, TALL1, CD257
- Chromosome:
- 13q33.3
- Locus Type:
- gene with protein product
- Date approved:
- 1999-07-19
- Date modifiied:
- 2018-11-22
Related products to: Rcombinant Cynomolgus TNFSF13B, Fc-tagged species: Cynomolgus
(Draxin) C1ORf187 Polyclonal Antibody Host Species: Rabbit Immunogen: peptide Epitope Location:(Draxin) C1ORf187, Host species: Rabbit, Polyclonal antibody*Fluconazole Testing Medium USE For fluconazole susceptibility testing by using Candida species.*Listeria Enrichment Broth,Modified USE For selective enrichment of Listeria species.*Listeria Selective Agar USE For selective isolation and cultivation of Listeria species from clinical specimens.*MRS Agar,Modified (Lactobacilli Heteroferm Screen Agar) USE For isolation and cultivation of Lactobacillus species from salad dressings.*MRS Broth, Modified (Lactobacillus Hetero ferm Screen Broth) USE For the isolation and cultivation of Lactobacillus species from foods.*Pentachloro Rose Bengal Yeast Extract Agar Base (PRYES Agar) USE For the cultivation and differentiation of nephrotoxin producing strains of Penicillium viridicatum and related species isolated f*Pentachloro Rose Bengal Yeast Extract Agar Base (PRYES Agar) USE For the cultivation and differentiation of nephrotoxin producing strains of Penicillium viridicatum and related species isolated f*RajHans Medium (Salmonella Differential Agar) (Twin Pack) USE For identification and differentiation of Salmonella species from memebrs of Enterobacteriaceae,especially Proteus species.*Salmonella Differential Agar (Twin Pack) (RajHans Medium) USE For identification and differentiation of Salmonella species from members of Enterobacteriaceae,especially Proteus species.*Salmonella Differential Agar,Modified (Twin Pack) USE For identification and differentiation of Salmonella species from the members of Enterobacteriaceae especially Proteus species.*Urea Broth (Filter Sterilizable) USE For identification of bacteria on the basis of urea utilization, specifically for the differentiation of Proteus species from Salmonella and Shigella species*Urea Broth (Filter Sterilizable) USE For identification of bacteria on the basis of urea utilization, specifically for the differentiation of Proteus species from Salmonella and Shigella species10x ELISA WASH BUFFER, Product Type Accessory Reagent, Specificity 10x ELISA WASH BUFFER, Target Species , Host N_A, Format Concentrate, Isotypes , Applications E, Clone Related articles to: Rcombinant Cynomolgus TNFSF13B, Fc-tagged species: Cynomolgus
- Despite medical advances, active tuberculosis (TB) remains difficult to diagnose, particularly in asymptomatic or paucibacillary cases lacking detectable pathogen evidence. Elevated oxidative stress is a hallmark of () infection, and the genes driving this process represent promising diagnostic biomarkers. Transcriptomic profiling captures dynamic host immune responses preceding clinical manifestations, while weighted gene co-expression network analysis (WGCNA) identifies functionally coherent gene modules. Integrating WGCNA with immune infiltration analysis, this study aimed to discover oxidative stress-related hub genes as robust biomarkers to address critical gaps in active TB detection and differential diagnosis. - Source: PubMed
Publication date: 2026/06/08
Shang XuetianJi XiuxiuDong JingYao SiyuZhang XinyueZhao YuehanJia HongyanHuang MailingWu YadongZhang LanyueZhu ChuanzhiZhang ZongdePan Liping - Immunoglobulin A nephropathy (IgAN) is a common immune-mediated kidney disease. Its pathogenesis involves dysregulated B cell activation, excessive production of galactose-deficient immunoglobulin A1 (Gd-IgA1), and formation of IgA immune complex, which collectively drive glomerular injury. Telitacicept, a fusion protein that blocks B cell activation pathways, may counteract these mechanisms, but observational data and reliable biomarkers of therapeutic response remain limited. - Source: PubMed
Publication date: 2026/05/29
Fu RaoGao JingyangZhang YuHe ZheDu Xuanyi - The neurotoxicity mechanisms of tetrachloro-1,4-benzoquinone(TCBQ) remain poorly understood. This study integrated computational simulations validation to elucidate TCBQ-induced neurotoxicity. - Source: PubMed
Publication date: 2026/06/09
Rong ChunshuWei ZhenXie DongeWang QingyuanRen HaoxuWang XuZhao Dexi - Rheumatoid arthritis (RA) and major depressive disorder (MDD) exhibit significant comorbidity, with shared pathological mechanisms such as inflammation and abnormal lipid metabolism. However, the specific molecular features and functional pathways linking the two diseases remain unclear. - Source: PubMed
Publication date: 2026/05/26
Liu JiaruXiang CuitianZhou QiruiDing ZhenzhuWang JingrongLi Arong - Despite achieving complete peripheral B cell deletion after over 6 months of rituximab therapy, a clinically significant minority of neuromyelitis optica spectrum disorder (NMOSD) patients experience breakthrough relapses, yet the underlying mechanism remains unclear. Our study aims to explore the underlying mechanism-the contribution of the MALAT1/miR-30b-5p/BAFF axis activation in monocytes to NMOSD disease attacks and relapses resistant to rituximab therapy. - Source: PubMed
Deng MeiqunZeng KeyiChen WeiChen JingLin XiaotingChen LeiYao YuxinChen HanfeiLin Aiyu